Home
Stocks
Aroa Biosurgery Ltd
Filings
Aroa Biosurgery Ltd (OTC:AROAF) Filings
Aroa Biosurgery Ltd
Filings
Filing
Date
Type
Filed with
US CMS Confirms Symphony Outpatient Reimbursement Rate
Nov 8, 2026
Guidance
ASX
Aroa Biosurgery H1 FY27 Results & Investor Event
Nov 3, 2026
Results
ASX
AROA Appoints Mark Dunwoodie as CFO
Nov 2, 2026
Management or board change
ASX
Change in substantial shareholding for ARX
Oct 18, 2026
Other filings
ASX
Molnlycke to Co-promote Endoform In the US
Oct 15, 2026
Other filings
ASX
Notification of cessation of securities - ARX
Oct 12, 2026
Financing
ASX
Investor Presentation - Symphony RCT
Oct 11, 2026
Other filings
ASX
Invite to Investor Webinar on Symphony RCT
Oct 6, 2026
Other filings
ASX
Investor Presentation - MASTRR Interim Analysis
Oct 6, 2026
Operations update
ASX
Change in substantial holding
Oct 6, 2026
Ownership change notice
ASX
Symphony Significantly Improves DFU Healing
Oct 4, 2026
Other filings
ASX
Invite to Investor Webinar on MASTRR Interim Analysis
Sep 28, 2026
Other filings
ASX
Myriad MASTRR Study Reports Low Infection Rates
Sep 3, 2026
Operations update
ASX
Change of Director's Interest Notice - BW
Aug 27, 2026
Ownership change notice
ASX
Notification regarding unquoted securities - ARX
Aug 27, 2026
Notification letter
ASX
Final Director's Interest Notice - JD
Aug 20, 2026
Ownership change notice
ASX
Results of Annual General Meeting
Aug 19, 2026
Meeting outcome
ASX
CEO Presentation - AGM
Aug 18, 2026
Other filings
ASX
Chairman's Address - AGM
Aug 18, 2026
Meeting outcome
ASX
Notification of cessation of securities - ARX
Aug 11, 2026
Financing
ASX
Notification regarding unquoted securities - ARX
Aug 11, 2026
Other filings
ASX
Change in substantial shareholding for ARX
Aug 6, 2026
Other filings
ASX
Notification regarding unquoted securities - ARX
Jul 27, 2026
Other filings
ASX
Commercial Leadership Appointments
Jul 27, 2026
Management or board change
ASX
FY26 Full Year Results Presentation
May 25, 2026
Results
ASX
FY26 Appendix 4E and Full Year Results
May 25, 2026
Results
ASX
ARX FY26 Preliminary Results
Apr 29, 2026
Results
ASX
Symphony Randomised Control Trial Complete
Mar 29, 2026
Other filings
ASX
AROA Business Update Presentation
Feb 2, 2026
Guidance
ASX
AROA Business Update
Feb 2, 2026
Operations update
ASX
Aroa Biosurgery H1 FY26 Results
Nov 24, 2025
Results
ASX
Appendix 4D and Half Year Report
Nov 24, 2025
Interim report
ASX
September 2025 Quarterly Report and Appendix 4C
Oct 15, 2025
Quarterly report
ASX
June 2025 Quarterly Report and Appendix 4C
Jul 28, 2025
Quarterly report
ASX
FY25 Full Year Results Presentation
May 28, 2025
Results
ASX
FY25 Appendix 4E and Full Year Results
May 28, 2025
Results
ASX
March 2025 Quarterly Report and Appendix 4C
Apr 28, 2025
Quarterly report
ASX
December 2024 Quarterly Report and Appendix 4C
Jan 28, 2025
Quarterly report
ASX
Aroa Half Year Results Presentation
Nov 25, 2024
Interim report
ASX
Aroa Biosurgery Half Yearly Results H1 FY25
Nov 25, 2024
Results
ASX
September 2024 Quarterly Report and Appendix 4C
Oct 21, 2024
Quarterly report
ASX
June 2024 Quarterly Report and Appendix 4C
Jul 23, 2024
Quarterly report
ASX
FY24 Full Year Results Presentation
May 20, 2024
Results
ASX
FY24 Appendix 4E and Full Year Results
May 20, 2024
Results
ASX
March 2024 Quarterly Report and Appendix 4C
Apr 29, 2024
Quarterly report
ASX
December 2023 Quarterly Report and Appendix 4C
Jan 29, 2024
Quarterly report
ASX
Aroa Biosurgery Half Yearly Results H1 FY24
Nov 27, 2023
Results
ASX
September 2023 Quarterly Report and Appendix 4C
Oct 30, 2023
Quarterly report
ASX
June 2023 Quarterly Report and Appendix 4C
Jul 30, 2023
Quarterly report
ASX
FY23 Full Year Results Presentation
May 30, 2023
Results
ASX
FY23 Appendix 4E and Full Year Results
May 30, 2023
Results
ASX
March 2023 Quarterly Report and Appendix 4C
Apr 26, 2023
Quarterly report
ASX
AROA secures first FDA clearance for ENIVO system
Apr 11, 2023
Other filings
ASX
December 2022 Quarterly Report and Appendix 4C
Jan 30, 2023
Quarterly report
ASX
Aroa Biosurgery Half Yearly Results H1 FY23
Nov 28, 2022
Interim report
ASX
September 2022 Quarterly Report and Appendix 4C
Oct 24, 2022
Quarterly report
ASX
June Quarterly Report and Appendix 4C
Jul 25, 2022
Quarterly report
ASX
FY22 Full Year Results Presentation
May 23, 2022
Results
ASX
FY22 Appendix 4E and Full Year Results
May 23, 2022
Results
ASX
March Quarterly Report and Appendix 4C
Apr 25, 2022
Quarterly report
ASX
December Quarterly Report and Appendix 4C
Jan 27, 2022
Quarterly report
ASX
Aroa Biosurgery Half Yearly Report H1 FY21
Nov 24, 2021
Interim report
ASX
September Quarterly Report and Appendix 4C
Oct 26, 2021
Quarterly report
ASX
Aroa delivers strong half, Myriad GPO win
Oct 5, 2021
Other filings
ASX
Investor Presentation
Jul 28, 2021
Other filings
ASX
Aroa Completes $47m Placement and Launches $5m SPP
Jul 28, 2021
Financing
ASX
Trading Halt
Jul 26, 2021
Trading halt or suspension
ASX
FY21 Full Year Results Presentation
May 24, 2021
Results
ASX
Preliminary Final Report
May 24, 2021
Results
ASX
Aroa secures FDA clearance for new product
Apr 5, 2021
Other filings
ASX
S&P DJI Announces March 2021 Quarterly Rebalance
Mar 12, 2021
Other filings
ASX
Aroa Half Year Results
Nov 25, 2020
Interim report
ASX
Aroa Biosurgery Secures FDA Clearance for Symphony
Jul 30, 2020
Other filings
ASX
European Approval Received for Myriad
Jul 29, 2020
Other filings
ASX